JP2013534902A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013534902A5 JP2013534902A5 JP2013501421A JP2013501421A JP2013534902A5 JP 2013534902 A5 JP2013534902 A5 JP 2013534902A5 JP 2013501421 A JP2013501421 A JP 2013501421A JP 2013501421 A JP2013501421 A JP 2013501421A JP 2013534902 A5 JP2013534902 A5 JP 2013534902A5
- Authority
- JP
- Japan
- Prior art keywords
- indol
- dihydro
- amine
- acetyl
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31747610P | 2010-03-25 | 2010-03-25 | |
| US61/317,476 | 2010-03-25 | ||
| US35286310P | 2010-06-09 | 2010-06-09 | |
| US61/352,863 | 2010-06-09 | ||
| US38148010P | 2010-09-10 | 2010-09-10 | |
| US61/381,480 | 2010-09-10 | ||
| US38815110P | 2010-09-30 | 2010-09-30 | |
| US61/388,151 | 2010-09-30 | ||
| US41906810P | 2010-12-02 | 2010-12-02 | |
| US61/419,068 | 2010-12-02 | ||
| PCT/US2011/029511 WO2011119663A1 (en) | 2010-03-25 | 2011-03-23 | Chemical compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013534902A JP2013534902A (ja) | 2013-09-09 |
| JP2013534902A5 true JP2013534902A5 (enExample) | 2014-05-08 |
| JP5876031B2 JP5876031B2 (ja) | 2016-03-02 |
Family
ID=46160738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013501421A Expired - Fee Related JP5876031B2 (ja) | 2010-03-25 | 2011-03-23 | 化合物 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20120077828A1 (enExample) |
| EP (1) | EP2549868B1 (enExample) |
| JP (1) | JP5876031B2 (enExample) |
| KR (1) | KR101676077B1 (enExample) |
| CN (1) | CN102917588B (enExample) |
| AR (1) | AR080792A1 (enExample) |
| AU (1) | AU2011232516B2 (enExample) |
| EA (1) | EA022325B1 (enExample) |
| ES (1) | ES2530955T3 (enExample) |
| IL (1) | IL222120A (enExample) |
| MX (1) | MX2012011045A (enExample) |
| SG (1) | SG183954A1 (enExample) |
| TW (1) | TW201202241A (enExample) |
| UY (1) | UY33288A (enExample) |
| WO (1) | WO2011119663A1 (enExample) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112012024380A2 (pt) | 2010-03-25 | 2015-09-15 | Glaxosmithkline Llc | compostos químicos |
| US20140227289A1 (en) * | 2011-05-13 | 2014-08-14 | Stephen Michael Cohen | Compounds and methods for treating insulin resistance syndrome |
| EP2548877A1 (en) | 2011-07-19 | 2013-01-23 | MSD Oss B.V. | 4-(5-Membered fused pyridinyl)benzamides as BTK-inhibitors |
| CN106243113B (zh) | 2011-07-19 | 2018-12-18 | 默沙东有限责任公司 | 作为btk抑制剂的选择的咪唑并吡嗪类 |
| JP6496246B2 (ja) * | 2012-10-05 | 2019-04-03 | メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． | アルドステロンシンターゼインヒビター関連用途としてのインドリン化合物 |
| TWI498325B (zh) * | 2013-01-18 | 2015-09-01 | Hoffmann La Roche | ３－取代吡唑及其用途 |
| EP2989091B1 (en) * | 2013-04-04 | 2017-05-10 | Janssen Pharmaceutica NV | Novel n-(2,3-dihydro-1h-pyrrolo[2,3-b]pyridin-5-yl)-4- quinazolinamine and n-(2,3-dihydro-1h-indol-5-yl)-4- quinazolinamine derivatives as perk inhibitors |
| TWI482757B (zh) * | 2013-10-07 | 2015-05-01 | Luminescence Technology Corp | Ｖｅｇｆ－２／３受體及蛋白質酪胺酸激酶抑制劑及其醫藥用途 |
| WO2015056180A1 (en) * | 2013-10-15 | 2015-04-23 | Glaxosmithkline Intellectual Property (No.2) Limited | Indoline derivatives as inhibitors of perk |
| AU2014358868A1 (en) | 2013-12-05 | 2016-06-09 | Acerta Pharma B.V. | Therapeutic combination of a PI3K inhibitor and a BTK inhibitor |
| US10272083B2 (en) | 2014-01-21 | 2019-04-30 | Acerta Pharma B.V. | Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor |
| EP3116877A1 (en) * | 2014-03-11 | 2017-01-18 | Glaxosmithkline Intellectual Property (No. 2) Limited | Chemical compounds acting as perk inhibitors |
| US9937171B2 (en) | 2014-04-11 | 2018-04-10 | Acerta Pharma B.V. | Methods of blocking the CXCR-4/SDF-1 signaling pathway with inhibitors of bruton's tyrosine kinase |
| WO2015193740A2 (en) | 2014-06-17 | 2015-12-23 | Acerta Pharma B.V. | Therapeutic combinations of a btk inhibitor, a pi3k inhibitor and/or a jak-2 inhibitor |
| EP3179991B1 (en) | 2014-08-11 | 2021-10-06 | Acerta Pharma B.V. | Therapeutic combinations of a btk inhibitor and a bcl-2 inhibitor |
| PT3461821T (pt) * | 2014-10-24 | 2020-08-05 | Bristol Myers Squibb Co | Compostos de indol carboxamida úteis como inibidores de quinase |
| CA2967125C (en) | 2014-11-14 | 2022-10-25 | Nerviano Medical Sciences S.R.L. | 6-amino-7-bicyclo-7-deaza-purine derivatives as protein kinase inhibitors |
| WO2016126026A2 (ko) * | 2015-02-04 | 2016-08-11 | 서울대학교병원 | 당뇨병 치료 조성물 및 이의 용도 |
| DK3954690T3 (da) | 2015-07-02 | 2023-06-06 | Acerta Pharma Bv | Faste former og formuleringer af (s)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-n-(pyridin-2-yl)benzamid |
| WO2017046739A1 (en) * | 2015-09-15 | 2017-03-23 | Glaxosmithkline Intellectual Property (No.2) Limited | Imidazolidinone derivatives as inhibitors of perk |
| TW201722957A (zh) * | 2015-09-15 | 2017-07-01 | 葛蘭素史克智慧財產（第二）有限公司 | 化學化合物 |
| PE20181884A1 (es) * | 2016-04-07 | 2018-12-07 | Glaxosmithkline Ip Dev Ltd | Amidas heterociclicas utiles como moduladores de proteinas |
| IL297192A (en) * | 2016-04-15 | 2022-12-01 | Cancer Research Tech Ltd | Heterocyclic compounds as ret kinase inhibitors |
| US11026945B2 (en) * | 2016-04-29 | 2021-06-08 | The Trustees Of The University Of Pennsylvania | Protein kinase RNA-like endoplasmic reticulum kinase (PERK) inhibitors for prevention and/or treatment of lung injury and/or inflammation |
| US10723706B2 (en) | 2016-06-13 | 2020-07-28 | Ramot At Tel-Aviv University Ltd. | Perk inhibitors and uses thereof in treating diseases associated with aggregation-prone proteins |
| WO2017220477A1 (en) | 2016-06-21 | 2017-12-28 | Nerviano Medical Sciences S.R.L. | N-(substituted-phenyl)-sulfonamide derivatives as kinase inhibitors |
| WO2018015879A1 (en) * | 2016-07-20 | 2018-01-25 | Glaxosmithkline Intellectual Property Development Limited | Isoquinoline derivatives as perk inhibitors |
| US11759437B2 (en) | 2016-09-22 | 2023-09-19 | The University Of Hong Kong | Preventive and therapeutic approach for aberrant cell differentiation and ISR-associated diseases |
| WO2018138358A1 (en) | 2017-01-30 | 2018-08-02 | Université de Liège | Perk and ire-1a inhibitors against neurodevelopmental disorders |
| CN106974910B (zh) * | 2017-03-02 | 2019-11-12 | 深圳大学 | 含索拉非尼和gsk2656157的药物组合物及用途 |
| CN106963769B (zh) * | 2017-03-03 | 2019-10-25 | 深圳大学 | 含pi3k抑制剂和perk抑制剂的药物组合物及其应用 |
| EP3593817B1 (en) * | 2017-03-06 | 2024-11-13 | Tsubota Laboratory, Inc. | Composition for use in the prevention or suppression of myopia |
| PT3448859T (pt) * | 2017-03-20 | 2019-10-25 | Forma Therapeutics Inc | Composições de pirrolopirrole como ativadores de piruvato quinase (pkr). |
| WO2019021208A1 (en) * | 2017-07-27 | 2019-01-31 | Glaxosmithkline Intellectual Property Development Limited | USEFUL INDAZOLE DERIVATIVES AS PERK INHIBITORS |
| CA3080971A1 (en) | 2017-11-02 | 2019-05-09 | Calico Life Sciences Llc | Modulators of the integrated stress pathway |
| CN108003163B (zh) * | 2017-11-30 | 2020-11-24 | 武汉九州钰民医药科技有限公司 | 用作激酶抑制剂的吡唑并嘧啶类化合物及其应用 |
| CN111100130B (zh) * | 2018-10-29 | 2022-07-15 | 四川大学 | 4-氨基吡咯并嘧啶衍生物及其制备方法和用途 |
| CN111213632B (zh) * | 2019-11-19 | 2022-03-01 | 长春中医药大学 | 动物药环氧树脂标本制作方法 |
| JP2023528659A (ja) | 2020-06-08 | 2023-07-05 | ハリア・セラピューティクス・インコーポレイテッド | Ｎｅｋ７キナーゼの阻害剤 |
| US20240100172A1 (en) | 2020-12-21 | 2024-03-28 | Hangzhou Jijing Pharmaceutical Technology Limited | Methods and compounds for targeted autophagy |
| WO2022212326A1 (en) | 2021-03-29 | 2022-10-06 | Halia Therapeutics, Inc. | Nek7 inhibitors |
| PH12023552774A1 (en) | 2021-04-05 | 2024-04-15 | Halia Therapeutics Inc | Nek7 inhibitors |
| WO2023034236A1 (en) * | 2021-08-31 | 2023-03-09 | Wisconsin Alumni Research Foundation | Deuterated inhibitors of rip kinases |
| GB202407386D0 (en) | 2024-05-24 | 2024-07-10 | Apollo Ap45 Ltd | 1H-pyrazolo(4,3-D)pyrimidine derivatives |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005110410A2 (en) * | 2004-05-14 | 2005-11-24 | Abbott Laboratories | Kinase inhibitors as therapeutic agents |
| JP4163738B2 (ja) * | 2004-06-11 | 2008-10-08 | 日本たばこ産業株式会社 | 癌の治療用の５−アミノ−２，４，７−トリオキソ−３，４，７，８−テトラヒドロ−２Ｈ−ピリド’２，３−ｄ！ピリミジン誘導体及び関連化合物 |
| JP2009514899A (ja) * | 2005-11-04 | 2009-04-09 | スミスクライン ビーチャム コーポレーション | チエノピリジンＢ−Ｒａｆキナーゼ阻害剤 |
| EP2368566A1 (en) * | 2006-07-13 | 2011-09-28 | ZymoGenetics, Inc. | Interleukin 21 and tyrosine kinase inhibitor combination therapy |
| WO2009151621A1 (en) * | 2008-06-13 | 2009-12-17 | Arena Pharmaceuticals, Inc. | Substituted (1, 2, 4-0xadiaz0l-3-yl) indolin-1-yl carboxylic acid derivatives useful as s1p1 agonists |
| EP2376492B1 (en) * | 2008-09-19 | 2015-04-08 | Nerviano Medical Sciences S.r.l. | 3,4 DIHYDRO-2H-PYRROLO[1,2-a]PYRAZIN-1-ONE DERIVATIVES |
-
2011
- 2011-03-22 UY UY0001033288A patent/UY33288A/es not_active Application Discontinuation
- 2011-03-23 WO PCT/US2011/029511 patent/WO2011119663A1/en not_active Ceased
- 2011-03-23 JP JP2013501421A patent/JP5876031B2/ja not_active Expired - Fee Related
- 2011-03-23 EA EA201290952A patent/EA022325B1/ru not_active IP Right Cessation
- 2011-03-23 US US13/069,569 patent/US20120077828A1/en not_active Abandoned
- 2011-03-23 EP EP11760102.1A patent/EP2549868B1/en active Active
- 2011-03-23 CN CN201180025962.7A patent/CN102917588B/zh not_active Expired - Fee Related
- 2011-03-23 MX MX2012011045A patent/MX2012011045A/es active IP Right Grant
- 2011-03-23 KR KR1020127027705A patent/KR101676077B1/ko not_active Expired - Fee Related
- 2011-03-23 AU AU2011232516A patent/AU2011232516B2/en not_active Ceased
- 2011-03-23 SG SG2012066379A patent/SG183954A1/en unknown
- 2011-03-23 TW TW100109800A patent/TW201202241A/zh unknown
- 2011-03-23 ES ES11760102T patent/ES2530955T3/es active Active
- 2011-03-23 AR ARP110100955A patent/AR080792A1/es not_active Application Discontinuation
-
2012
- 2012-09-24 IL IL222120A patent/IL222120A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013534902A5 (enExample) | ||
| JP5911638B2 (ja) | ベンゾチアゾール−６−イル酢酸誘導体およびｈｉｖ感染を処置するためのそれらの使用 | |
| CN112204027A (zh) | Erk 抑制剂及其应用 | |
| ES2540996T3 (es) | Compuestos de N-(1H-indazol-4-il)imidazo[1,2-a]piridin-3-carboxamida sustituidos como inhibidores de tirosina cinasa del receptor de tipo III | |
| JP2022185110A (ja) | Ｃ－ｋｉｔ阻害剤としてのベンズイミダゾール化合物 | |
| HRP20200624T1 (hr) | Derivati 2-(2,4,5-supstituiranog-anilino)pirimidina kao modulatori egfr korisni za liječenje raka | |
| RU2019115115A (ru) | Производные пиперидина в качестве ингибиторов убиквитин-специфической протеазы 7 | |
| JP2019535664A5 (enExample) | ||
| JP2020531498A5 (enExample) | ||
| RU2018123779A (ru) | Новые соединения | |
| WO2018218133A1 (en) | Pyrazolo[3,4-b]pyrazine derivatives as shp2 phosphatase inhibitors | |
| JP2009529047A5 (enExample) | ||
| HRP20120105T1 (hr) | Aminoheterociklički spojevi | |
| RU2012131124A (ru) | Птеридиноны как ингибиторы polo-подобных киназ | |
| JP2010539177A5 (enExample) | ||
| JP2018500376A5 (enExample) | ||
| HRP20170349T1 (hr) | Novi derivati pirola, postupak njihove priprave i farmaceutski pripravci koji ih sadrže | |
| ME02514B (me) | Derivati 8 -karbamoil- 2-(2,3-disupstituirani pirid-6- il)-1,2,3,4-tetrahidroizokinolina kao sredstva za izazivanje apoptoze za liječenje karcinoma i imunih i autoimunih bolesti | |
| JP2010512338A5 (enExample) | ||
| AU2013225533A1 (en) | Amido spirocyclic amide and sulfonamide derivatives | |
| JP2013515729A5 (enExample) | ||
| JPWO2011078221A1 (ja) | イミダゾピリダジン化合物 | |
| JP2012525367A5 (enExample) | ||
| RU2018113430A (ru) | Производные l-фенилпирролидин-2-она в качестве ингибиторов perk | |
| RU2011125314A (ru) | Новое производное пиразол-3-карбоксамида, обладающее антагонистической активностью в отношении рецептора 5-нт2в |